042 – Biotech M&As accelerate. IMMU’s ADC shakes up breast cancer!

Today, I cover the latest in biotech with a highlight on Immunomedics and their antibody-drug conjugates for breast cancer.

*this is not investment advice*
http://www.breakingbiotech.com
@matthewlepoire

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s